Thomas Jackson
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
-
- Protein Degradation and Inhibitors 3
- RNA Interference and Gene Delivery 3
- Histone Deacetylase Inhibitors Research 2
- Pluripotent Stem Cells Research 2
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Paul A. Townsend (8 shared papers)Kristīne Salmiņa (4 shared papers)Jekaterina Ērenpreisa (4 shared papers)Mark S. Cragg (4 shared papers)Anda Huna (4 shared papers)Alejandro Vázquez‐Martín (2 shared papers)Anindita Roy (5 shared papers)Inna Inashkina (3 shared papers)
- Journals
- Cell Cycle (3 papers)Blood (3 papers)Oncotarget (2 papers)European Journal of Medicinal Chemistry (1 paper)Scientific Reports (1 paper)
- Partner nations
- United KingdomUnited StatesLatvia
In The Last Decade
Thomas Jackson
21 papers receiving 438 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 82
- Aging 8
- Hematology 44
- Cell Biology 61
- Molecular Biology 255
Countries citing papers authored by Thomas Jackson
This map shows the geographic impact of Thomas Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jackson more than expected).
Fields of papers citing papers by Thomas Jackson
This network shows the impact of papers produced by Thomas Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jackson. The network helps show where Thomas Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 69 | |
| 2 | 2015 | 54 | |
| 3 | 2017 | 43 | |
| 4 | 2016 | 43 | |
| 5 | 2008 | 39 | |
| 6 | 2013 | 37 | |
| 7 | 2021 | 28 | |
| 8 | 2015 | 26 | |
| 9 | 2020 | 20 | |
| 10 | 2021 | 18 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 14 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2023 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2022 | 1 |
About Thomas Jackson
Thomas Jackson is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Hematology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 23 papers that have together received 446 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (3 papers), RNA Interference and Gene Delivery (3 papers), Prenatal Screening and Diagnostics (2 papers), Cancer Genomics and Diagnostics (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Cancer Research (82 citations), Aging (8 citations), Hematology (44 citations), Cell Biology (61 citations) and Molecular Biology (255 citations). Thomas Jackson has collaborated with scholars based in United Kingdom, United States and Latvia. Frequent co-authors include Paul A. Townsend, Kristīne Salmiņa, Jekaterina Ērenpreisa, Mark S. Cragg, Anda Huna, Alejandro Vázquez‐Martín, Anindita Roy, Inna Inashkina, Rebecca E. Ling and Hannah Harrison. Their work appears in journals such as Cell Cycle, Blood, Oncotarget, European Journal of Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.